logo
episode-header-image
Feb 2021
20m 59s

Like hell out of a bat: SARS-CoV-2’s ori...

The Economist
About this episode

The World Health Organisation unveiled preliminary findings, suggesting the coronavirus probably jumped to humans via an intermediary animal and all but ruling out a laboratory leak. We examine the many remaining questions. Nefarious regimes find it ever easier to reach across borders, subjecting dissidents to repression and surveillance abroad. And why it’s so hard to buy a car in Algeria. 

For full access to print, digital and audio editions of The Economist, subscribe here www.economist.com/intelligenceoffer

“The Jab from Economist Radio” is our new weekly podcast at the sharp end of the global vaccination race. Listen to the trailer and subscribe now

 

See acast.com/privacy for privacy and opt-out information.

Up next
Today
Sprawl of duty: Trump’s tariff drama
Once again President Donald Trump extended the deadline for spine-stiffening tariffs to go into effect on trading partners. We look at the effects of all the uncertainty. Brazil once dominated the world of football; we ask where it went wrong and assess the route to a comeback. A ... Show More
21m 53s
Yesterday
The French reconnection: Macron in Britain
Anglo-French relations have not been so good since before the Brexit vote. Beneath the state-visit pageantry, though, there is much co-operation for President Emmanuel Macron and Prime Minister Keir Starmer to discuss. Gangs have infiltrated many of Latin America’s mining operati ... Show More
21m 10s
Jul 7
Trump card: can he broker a Gaza deal?
While Israel and Hamas officials discuss a ceasefire via mediators in Qatar, a key meeting will take place at the White House today, when Israel’s prime minister talks to the US president. Why the Chinese Communist Party is removing alcohol from official events. And remembering J ... Show More
21m 7s
Recommended Episodes
Mar 2021
The Jab: How will behaviour change?
The world has stumbled through the pandemic by nationalising risk. In heavily infected countries citizens have been ordered to stay home for weeks at a time. As covid-19 vaccination programmes spread, governments must gradually restore choice to the individual. How? We speak to O ... Show More
40m 13s
Apr 2021
Babbage: Post-covid syndrome
As research on long covid advances, how should countries respond to the impending public health emergency? Also, new hope in the fight against malaria in the form of a highly effective vaccine. And, why the sound of nature might be good for your health. Kenneth Cukier hosts  A no ... Show More
27m 56s
Apr 2021
Babbage: Where it began
Almost a year and a half since the discovery of the virus that causes covid-19, The Economist’s health policy editor, Natasha Loder, investigates one of the pandemic’s most compelling mysteries: where did SARS-CoV-2 come from? Peter Daszak, who was part of the World Health Organi ... Show More
35m 11s
May 2021
On the origins and the specious: the SARS-CoV-2 lab-leak theory
The suggestion that the virus first emerged from a Chinese laboratory has proved stubbornly persistent; as calls mount for more investigation, it has become a potent epidemiological and political idea. Latin America’s strict lockdowns have had the expected calamitous economic eff ... Show More
20m 43s
Feb 2021
The Jab: Trailer
In this new weekly podcast series, The Economist unlocks the science, data and politics behind the most ambitious inoculation programme the world has ever seen. Alok Jha, The Economist’s science correspondent, hosts with Natasha Loder, our health policy editor. Each week our repo ... Show More
1m 40s
Sep 2023
A better pill to swallow: the bid to end AIDS
Many of the pieces are in place to bring the disease entirely under control—but our correspondent finds it will take more than advances in medication. Japan’s government has at last begun to regulate the country’s notorious pornography; we examine a sector emerging from the shado ... Show More
24m 58s
May 2020
The race for a vaccine, the story behind EBITDAC, BoE’s Bailey
The hunt for a coronavirus vaccine is central to global efforts to restart economies. The FT’s US coronavirus correspondent, David Crow, explains how nationalism could slow the fight against the pandemic. Plus, some companies are presenting a new customised metric they are callin ... Show More
9m 45s
Oct 2023
Genocide returns: slaughter in Sudan
From a refugee camp in Chad, we speak with those fleeing murder in Darfur. Reporting on the war between the Sudanese Armed Forces and a powerful paramilitary group may have slowed, but the suffering has not. Bowel cancer is becoming more common in young people. How can screening ... Show More
27m 20s
Feb 2024
The obesity drug craze is entering its next phase
Eli Lilly and Novo Nordisk can’t keep up with demand for their weight loss medications. In this Viewsroom podcast, Breakingviews columnists discuss the hype among celebrities, the different approaches to prescribing them in the US and Europe, and how they can reshape the world. V ... Show More
22m 46s